Insulin aspart 100 unit/ML pen 3ML
Ended Awarded Last action
- Contract number
- SPE2DR26FFK9Q
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $2,599
Award facts
- Contract value 100% obligated
- $2,598.80 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $2,598.80 firm fixed-price delivery order to AmerisourceBergen Drug Corp (parent company Cencora, Inc.) on January 16, 2026, for the supply of Insulin Aspart 100 Unit/ML pens in 3ML configurations. The order, which is expected to be completed by January 20, 2026, was placed under a competitive procurement with no set-aside designation. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is performing the work at its corporate office location. This delivery order represents a task order under the company's larger Indefinite Delivery Contract with DLA Troop Support Medical, valued at up to $999,999,999.00 through December 2026, which serves as a comprehensive global pharmaceutical support vehicle enabling supply of a vast range of pharmaceutical products and medical supplies to military healthcare programs worldwide.
AmerisourceBergen Drug Corp, a major pharmaceutical distributor and critical vendor for federal medical procurement, regularly fulfills delivery orders through this prime indefinite delivery contract covering medications across multiple therapeutic domains including specialty medications, brand-name and generic drugs, vaccines, and medical supplies. The DLA Troop Support Medical contract enables the company to serve customers including the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems. The insulin delivery under this order supports military healthcare programs' diabetes management requirements, demonstrating the company's role in supplying essential pharmaceutical commodities to federal medical institutions.
Quick answers
Who was awarded contract SPE2DR26FFK9Q?
SPE2DR26FFK9Q was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 16, 2026.
How much is contract SPE2DR26FFK9Q worth?
The government has obligated $2,599 on SPE2DR26FFK9Q.
Is contract SPE2DR26FFK9Q an order under another contract?
Yes. SPE2DR26FFK9Q is a delivery order under SPE2DR25D1109, an indefinite delivery contract.
Was contract SPE2DR26FFK9Q competed?
The extent of competition for SPE2DR26FFK9Q was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award